Chemistry professor Carla Mattos spends much of her time studying a protein known as RAS. It is important in cell proliferation, and until recently has been com­pletely elu­sive as a drug target, she told News@Northeastern's Angela Herring.

Dan Shea focuses his work on BPAs -- not the ones associated with plastics, but rather a class of anti-cancer drugs that also has anti-microbial properties.

Northeastern University’s own Dr. Thomas R. Gilbert, an associate professor of chemistry and chemical biology, was recently elected to the American Chemical Society Board of Directors. He will serve as the director for District I, which includes New England, New York, and parts of Pennsylvania.

The foren­sics lab isn’t nearly as glam­orous as tele­vi­sion would have you think. Jacquelyn Horman would know. The chem­istry major had watched her fair share of the police pro­ce­dural dramas NCIS and CSI: Miami before landing a co-​​op job with the crime lab at the Mesa, Ariz., police depart­ment. The lab work — not glitzy but crit­ical to inves­ti­ga­tions — strength­ened her interest in the field, she said.

North­eastern University’s stu­dent chapter of the Amer­ican Chem­ical Society has been des­ig­nated as “out­standing,” the highest honor bestowed upon a uni­ver­sity by the world’s largest sci­en­tific society.

It has been a whirlwind 10 months for new Northeastern University professor Carla Mattos. She moved to Boston, set up a new lab in structural biology, and won a highly competitive grant for a piece of new equipment that will expand research opportunities for the entire Northeastern community.

Ninety per­cent of global health­care and med­ical research money is spent on dis­eases that affect only 10 per­cent of the pop­u­la­tion, according to Michael Pol­lastri, a pro­fessor of chem­istry and chem­ical biology who spoke at the Col­lege of Sci­ence Col­lo­quium last Friday.

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.

Researchers at Northeastern University and the Dana-Farber Cancer Institute have long recognized and taken advantage of the complementary strengths of the two institutions. “Our collaboration with Dana-Farber has been rich over the years,” said Stephen Zoloth, Northeastern’s dean of academic affairs for external programs and vice provost for health research. “But it has generally been […]

For the first time in its nearly two decade history, this year’s World Health Report — issued biannually by the World Health Organization intended to help countries, donor agencies, international organizations and others make policy and funding decisions — will focus on the theme of research for better health. In anticipation of the report’s release, […]

Northeastern University hosted a ribbon-cutting ceremony on Wednesday to commemorate the new home of the Waters Laboratory at 140 The Fenway. The lab, designated as a Waters Center of Innovation, is run by John R. Engen, professor of chemistry, and is the cornerstone of the university’s 40-year partnership with the Massachusetts-based Waters Corporation — a […]